Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | BSX | GILD |
|---|
| Close | 43.91 | 147.68 |
| Market Cap | $63.6B | $183B |
| 1M | −14.62% | +6.31% |
| P/E (TTM) | 17.3 | — |
| Forward P/E | 13.4 | 25.3 |
| P/E 5-Yr Percentile | 0 | — |
| P/S | 3.0 | 6.0 |
| P/B | 2.6 | 15.3 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $5.4B | $7.8B |
| Revenue YoY | +7.5% | +10.2% |
| Gross Margin | 70.7% | 79.8% |
| Latest Quarter EPS | 0.61 | -8.45 |
| Avg Post-Earnings Move | ±1.5% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 3.01% |
| 90-Day Net Insider Buying | +$9.5M | −$15.4M |
BSX · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
